New study indicates Ebola vaccine safe and produces robust immune response
Scientists from the University of Oxford, working as part of the EBOVAC2 EBL2001 study group, have today announced the results of a phase 2 trial of a replication-deficient adenovirus vaccine aimed at providing protection ...
Nov 18, 2020
0
8